Clinical Trial Update: Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. [Phase 2]

View source ↗

Summary

This update notes a Phase 2 neoadjuvant trial of letrozole for postmenopausal women with HR-positive, HER2-negative, node-positive breast cancer, and the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Cancer Care Hospital & Research Centre Foundation, Lahore | Conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING